The management of Cushing disease continues to evolve with the availability of targeted medical therapies for patients with persistent or recurrent hypercortisolism after surgery or when surgery is not feasible. Understanding the mechanisms and clinical indications of these therapies is increasingly important in endocrine practice. Here is a quick question on the contemporary management of Cushing disease! (Scroll down to answer the question) ##Reference## Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab.
2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29. PMID: 26222757; PMCID: PMC4525003.## ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its…
